• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
ARCHITECTURAL PATTERNS FOR DIFFERENTIAL DIAGNOSIS OF PROLIFERATIVE BREAST LESIONS FROM HISTOPATHOLOGICAL IMAGES.基于组织病理学图像的乳腺增生性病变鉴别诊断的架构模式
Proc IEEE Int Symp Biomed Imaging. 2017 Apr;2017:152-155. doi: 10.1109/ISBI.2017.7950490. Epub 2017 Jun 19.
2
Computational pathology to discriminate benign from malignant intraductal proliferations of the breast.利用计算病理学鉴别乳腺导管内良性与恶性增殖病变。
PLoS One. 2014 Dec 9;9(12):e114885. doi: 10.1371/journal.pone.0114885. eCollection 2014.
3
Assessment of Machine Learning of Breast Pathology Structures for Automated Differentiation of Breast Cancer and High-Risk Proliferative Lesions.基于机器学习的乳腺病理学结构评估在乳腺癌和高危增殖性病变自动鉴别中的应用。
JAMA Netw Open. 2019 Aug 2;2(8):e198777. doi: 10.1001/jamanetworkopen.2019.8777.
4
Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.乳腺实性乳头状原位癌与普通导管增生:细胞角蛋白5/6解决的潜在难题鉴别
Hum Pathol. 2006 Jul;37(7):787-93. doi: 10.1016/j.humpath.2006.02.016. Epub 2006 May 26.
5
Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ.伴有或不伴有非典型性的导管增生及导管原位癌的细针穿刺细胞学检查
Hum Pathol. 1994 May;25(5):485-92. doi: 10.1016/0046-8177(94)90120-1.
6
[Role of cytokeratin expression in differential diagnosis of intraductal proliferative lesions of breast].[细胞角蛋白表达在乳腺导管内增生性病变鉴别诊断中的作用]
Zhonghua Bing Li Xue Za Zhi. 2004 Aug;33(4):316-9.
7
Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ.雌激素受体和细胞角蛋白5是区分普通导管增生与非典型导管增生及低级别导管原位癌的可靠标志物。
Arch Pathol Lab Med. 2016 Jul;140(7):686-9. doi: 10.5858/arpa.2015-0238-OA. Epub 2016 Apr 26.
8
Nuclear cytometric changes in breast carcinogenesis.乳腺癌发生过程中的细胞核细胞计量学变化。
J Pathol. 2001 Jan;193(1):33-9. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH744>3.0.CO;2-Q.
9
Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.基质金属蛋白酶9和基质金属蛋白酶组织抑制剂1在乳腺良恶性组织中的免疫组织化学研究——在乳腺导管内癌中强表达
Tumour Biol. 2009;30(5-6):257-64. doi: 10.1159/000253662. Epub 2009 Oct 31.
10
Quantitative nucleic features are effective for discrimination of intraductal proliferative lesions of the breast.定量核酸特征对乳腺导管内增生性病变的鉴别诊断有效。
J Pathol Inform. 2016 Jan 29;7:1. doi: 10.4103/2153-3539.175380. eCollection 2016.

本文引用的文献

1
Automated Detection of DCIS in Whole-Slide H&E Stained Breast Histopathology Images.全 slides 苏木精和伊红染色的乳腺组织病理学图像中 DCIS 的自动检测。
IEEE Trans Med Imaging. 2016 Sep;35(9):2141-2150. doi: 10.1109/TMI.2016.2550620. Epub 2016 Apr 5.
2
Identifying and processing the gap between perceived and actual agreement in breast pathology interpretation.识别并处理乳腺病理诊断中感知到的一致性与实际一致性之间的差距。
Mod Pathol. 2016 Jul;29(7):717-26. doi: 10.1038/modpathol.2016.62. Epub 2016 Apr 8.
3
Differential Diagnosis of Proliferative Breast Lesions.乳腺增生性病变的鉴别诊断
Surg Pathol Clin. 2009 Jun;2(2):235-46. doi: 10.1016/j.path.2009.02.002. Epub 2009 Jun 2.
4
Diagnostic concordance among pathologists interpreting breast biopsy specimens.解读乳腺活检标本的病理学家之间的诊断一致性。
JAMA. 2015 Mar 17;313(11):1122-32. doi: 10.1001/jama.2015.1405.
5
Computational pathology to discriminate benign from malignant intraductal proliferations of the breast.利用计算病理学鉴别乳腺导管内良性与恶性增殖病变。
PLoS One. 2014 Dec 9;9(12):e114885. doi: 10.1371/journal.pone.0114885. eCollection 2014.
6
Multilevel segmentation of histopathological images using cooccurrence of tissue objects.基于组织对象共现的组织病理图像多层次分割。
IEEE Trans Biomed Eng. 2012 Jun;59(6):1681-90. doi: 10.1109/TBME.2012.2191784. Epub 2012 Mar 23.
7
Graph run-length matrices for histopathological image segmentation.用于组织病理学图像分割的图游程长度矩阵。
IEEE Trans Med Imaging. 2011 Mar;30(3):721-32. doi: 10.1109/TMI.2010.2094200. Epub 2010 Nov 22.

基于组织病理学图像的乳腺增生性病变鉴别诊断的架构模式

ARCHITECTURAL PATTERNS FOR DIFFERENTIAL DIAGNOSIS OF PROLIFERATIVE BREAST LESIONS FROM HISTOPATHOLOGICAL IMAGES.

作者信息

Nguyen L, Tosun A B, Fine J L, Taylor D L, Chennubhotla S C

机构信息

Department of Computational and Systems Biology, University of Pittsburgh.

Drug Discovery Institute, University of Pittsburgh.

出版信息

Proc IEEE Int Symp Biomed Imaging. 2017 Apr;2017:152-155. doi: 10.1109/ISBI.2017.7950490. Epub 2017 Jun 19.

DOI:10.1109/ISBI.2017.7950490
PMID:28890755
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5589141/
Abstract

The differential diagnosis of proliferative breast lesions, benign usual ductal hyperplasia (UDH) versus malignant ductal carcinoma in situ (DCIS) is challenging. This involves a pathologist examining histopathologic sections of a biopsy using a light microscope, evaluating tissue structures for their architecture or size, and assessing individual cell nuclei for their morphology. Imposing diagnostic boundaries on features that otherwise exist on a continuum going from benign to atypia to malignant is a challenge. Current computational pathology methods have focused primarily on nuclear atypia in drawing these boundaries. In this paper, we improve on these approaches by encoding for both cellular morphology and spatial architectural patterns. Using a publicly available breast lesion database consisting of UDH and three different grades of DCIS, we improve the classification accuracy by 10% over the state-of-the-art method for discriminating UDH and DCIS. For the four way classification of UDH and the three grades of DCIS, our method improves the results by 6% in accuracy, 8% in micro-AUC, and 19% in macro-AUC.

摘要

增殖性乳腺病变的鉴别诊断颇具挑战性,其中良性的普通导管增生(UDH)与恶性的导管原位癌(DCIS)的鉴别尤为困难。这需要病理学家使用光学显微镜检查活检组织的病理切片,评估组织结构的架构或大小,并评估单个细胞核的形态。要在从良性到非典型增生再到恶性的连续特征上划定诊断界限是一项挑战。当前的计算病理学方法主要集中在通过核异型性来划定这些界限。在本文中,我们通过对细胞形态和空间结构模式进行编码来改进这些方法。使用一个公开可用的乳腺病变数据库,该数据库包含UDH和三种不同级别的DCIS,我们在区分UDH和DCIS方面比现有最先进的方法将分类准确率提高了10%。对于UDH和三种DCIS级别的四分类,我们的方法在准确率上提高了6%,在微AUC上提高了8%,在宏AUC上提高了19%。